The mRNA levels of CD4, HLA-DRB1, HLA-DRA, and ESR1 were positively correlated with OS, recurrence free survival and distant metastasis free survival in HER2-BC patients (Figs. 8–11 and Table 1). This evidence concerns the gene HLA-DRA and breast cancer.